V. Parlier

Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome

V. Parlier, Guy van Melle, P Beris et al. · Cancer Genetics and Cytogenetics · 1994 · 66 citations

Medicine, Genetics, Hematology +14

Cytogenetic analysis of 54 cases of myelodysplastic syndrome

M Jotterand-Bellomo, V. Parlier, P.M. Schmidt et al. · Cancer Genetics and Cytogenetics · 1990 · 58 citations

Life Sciences, Genetics, Hematology +14

CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameterfor the diagnosis and classification of myelodysplastic syndromes

Audrey Sylvia Baur, C Meugé‐Moraw, Pierre‐Michel Schmidt et al. · European Journal Of Haematology · 2000 · 39 citations

Medicine, Hematology, Pathology +13

Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics

Valérie Beyer, Chantal Castagné, Dominique Mühlematter et al. · Cancer Genetics and Cytogenetics · 2004 · 39 citations

Life Sciences, Genetics, Hematology +17

Prediction of 18-month survival in patients with primary myelodysplastic syndrome a regression model and scoring system based on the combination of chromosome findings and the bournemouth score

V. Parlier, Guy van Melle, P Beris et al. · Cancer Genetics and Cytogenetics · 1995 · 33 citations

Medicine, Hematology, Oncology +14